arrow
P

Peter Sandner

Bayer AG
H指数:41
被引数:5,443

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

sGC stimulator BAY 41-8543 improves survival and ventricular function in a rat model of doxorubicin-induced cardiomyopathy with nephrotic syndrome

sGC刺激剂BAY 41-8543改善由多柔比星诱导伴有肾病综合征的大鼠心肌病模型的生存率和心室功能

2026-07-290
OAAI
Pharmacological activation of NO-cGMP signalling attenuates metabolic dysfunction-associated steatohepatitis

通过药理学激活NO-cGMP信号通路可减轻代谢功能障碍相关脂肪性肝炎

2026-07-290
OAAI
Soluble guanylate cyclase stimulation improves cardiac function and mitochondrial activity in a rat model of early-stage heart failure with preserved ejection fraction

可溶性鸟苷酸环化酶刺激改善了射血分数保留的早期心力衰竭大鼠模型中的心功能和线粒体活性。

2025-08-120
PREAI
Effects of soluble guanylyl cyclase stimulation on muscle oxygenation and exercise capacity in heart failure with mildly reduced ejection fraction

可溶性鸟苷酸环化酶刺激对轻度射血分数降低的心力衰竭患者肌肉氧合和运动能力的影响

2025-06-190
OA
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension
2023-04-115
PRE
CYB5R3 in type II alveolar epithelial cells protects against lung fibrosis by suppressing TGF-β1 signaling
2023-03-084
OA
Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation
2022-12-129
OAAI